A Tranz-Life initiative for psoriasis sufferers – a hope in the form of better disease understanding and newer biologics
Most of the time psoriasis is a visible skin disease and these patients are ridiculed and discriminated. Thus efforts are required to raise awareness that psoriasis is not a contagious disease. These views were expressed by Prof. Joachim W. Herzig, from Faculty of Medicine, Johannes Gutenberg University, at a seminar entitled Psoriasis/Psoriatic Arthritis – Autoimmune and Molecular Insights that was held at the Auditorium, Convention Center, Liaquat National Hospital (LNH). The seminar was a combined effort of Rheumatology Department, LNH and Tranz-Life, an emerging company paving the future of healthcare. The mission of Tranz-Life is to be partners in innovation for disease management, collaborating with centers of excellence for disease awareness and clinical research and supporting informed patient decisions. Tranz-Life also offers its services to pharmaceutical industry for their growth transformation through contract sales and patient awareness/assistance programs.
In his keynote address, Prof. Herzig stated that more than 120 million people worldwide suffer from psoriasis many of whom are undertreated and are not offered the new treatment modalities. He highlighted the suffering and stigmas associated with the disease. He shared the data from CLEAR, SCULPTURE, UNCOVER-3 and FUTURE-2 studies and the response rates to secukinumab, Ixekizumab and Brodalumab, all IL-17A inhibitors. He concluded his talk by pointing out that the third generation biologics may be regarded as the new standard of treatment for psoriasis and psoriatic arthritis.
Earlier, in her welcome address Dr. Tahira Perveen appreciated the presence of Prof. Herzig to update the knowledge of local healthcare professionals. Dr. Perveen and Dr. Sana Gul from JMCH presented cases of psoriasis and psoriatic arthritis. The expert panelists opined that proper counseling of the patient and family along with education is of utmost importance not only in proper management but also to overcome the psychosocial aspects of the disease.
A lively question and answers session followed the case presentations. The seminar was very well attended both by senior medical professionals and residents who were of the opinion that newer biologicals must be introduced in Pakistan to benefit psoriasis patients which showed their interest in managing such undertreated and stigmatized diseases with newer therapeutic agents. The participants also lauded the role of Tranz-Life in bringing international speaker to Pakistan at a time when many foreign professionals are reluctant to visit Pakistan.